Sign in
4

Changes in Ownership

Immunome Inc. Filed Acc 0001104659-21-075233

Options or other derivatives

  • Chief Development Officer acquired 16,609 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Giesing Dennis H · Chief Development Officer

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2021-05-28 Grant or award : show line 1 in the form Stock Option (Right to Buy) +16,609 $20.92 2031-05-28 16,609 16,609 D
Loading xslF345X03/tm2118079d2_4seq1.xml…